BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31792553)

  • 1. [Prevalence and incidence of documented diabetes based on health claims data-reference analysis for diabetes surveillance in Germany].
    Schmidt C; Reitzle L; Dreß J; Rommel A; Ziese T; Heidemann C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):93-102. PubMed ID: 31792553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Algorithm for the Classification of Type 1 and Type 2 Diabetes Mellitus for the Analysis of Routine Data].
    Reitzle L; Ihle P; Heidemann C; Paprott R; Köster I; Schmidt C
    Gesundheitswesen; 2023 Mar; 85(S 02):S119-S126. PubMed ID: 35654399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimating prevalent microvascular complications of diabetes mellitus in Germany. Analysis of statutory health insurance data in 2012 and 2013].
    Reitzle L; Schmidt C; Du Y; Icks A; Hagen B; Ziese T; Scheidt-Nave C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Oct; 63(10):1219-1230. PubMed ID: 32876717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013-2014.
    Schmidt C; Reitzle L; Heidemann C; Paprott R; Ziese T; Scheidt-Nave C; Baumert J
    BMJ Open; 2021 Jan; 11(1):e041508. PubMed ID: 33408205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Secondary data analysis of the prevalence of alcohol dependence (F10.2) in Germany].
    van der Linde K; Wasem J; Lux G
    Dtsch Med Wochenschr; 2014 Nov; 139(45):2285-9. PubMed ID: 25350241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes--prevalence and cost of illness in Germany: a study evaluating data from the statutory health insurance in Germany.
    Stock SA; Redaelli M; Wendland G; Civello D; Lauterbach KW
    Diabet Med; 2006 Mar; 23(3):299-305. PubMed ID: 16492214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany--a retrospective cohort and case control study in claims data of a large statutory health insurance.
    Boehme MW; Buechele G; Frankenhauser-Mannuss J; Mueller J; Lump D; Boehm BO; Rothenbacher D
    BMC Public Health; 2015 Sep; 15():855. PubMed ID: 26334523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence and Incidence of Diabetes in Germany.
    Tamayo T; Brinks R; Hoyer A; Kuß OS; Rathmann W
    Dtsch Arztebl Int; 2016 Mar; 113(11):177-82. PubMed ID: 27118665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence trend of type 2 diabetes from 2012 to 2021 in Germany: an analysis of health claims data of 11 million statutorily insured people.
    Lehner CT; Eberl M; Donnachie E; Tanaka LF; Schauberger G; Schederecker F; Himmler S; Sundmacher L; Klug SJ
    Diabetologia; 2024 Jun; 67(6):1040-1050. PubMed ID: 38409438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mental disorders of working age : Evaluation of the administrative incidence and prevalence as well as regional differences in Lower Saxony on the basis of secondary data from a statutory health insurance provider].
    Gerdau-Heitmann C; Mümken S; Eberhard S; Koppelin F
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Dec; 60(12):1346-1355. PubMed ID: 29063157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rehabilitation in geriatric patients after ischemic stroke--a comparison of 2 organisational systems in Germany using claims data of a statutory health insurance fund].
    Abbas S; Ihle P; Hein R; Schubert I
    Rehabilitation (Stuttg); 2013 Dec; 52(6):375-82. PubMed ID: 23824567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare utilization of people with type 2 diabetes in Germany: an analysis based on health insurance data.
    Müller N; Heller T; Freitag MH; Gerste B; Haupt CM; Wolf G; Müller UA
    Diabet Med; 2015 Jul; 32(7):951-7. PubMed ID: 25781644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology and health care utilization of patients suffering from Huntington's disease in Germany: real world evidence based on German claims data.
    Ohlmeier C; Saum KU; Galetzka W; Beier D; Gothe H
    BMC Neurol; 2019 Dec; 19(1):318. PubMed ID: 31823737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of the incidence of diabetes in the Federal Republic of Germany based on insurance data. A secondary data analysis of a representative random sample of locally insured persons in the city of Dortmund].
    Hauner H; von Ferber L; Köster I
    Dtsch Med Wochenschr; 1992 Apr; 117(17):645-50. PubMed ID: 1572247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000-2009 Nationwide Health Insurance database.
    Jiang YD; Chang CH; Tai TY; Chen JF; Chuang LM
    J Formos Med Assoc; 2012 Nov; 111(11):599-604. PubMed ID: 23217595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5.43 million patients].
    Wilke T; Ahrendt P; Schwartz D; Linder R; Ahrens S; Verheyen F
    Dtsch Med Wochenschr; 2013 Jan; 138(3):69-75. PubMed ID: 23299340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].
    Hense S; Luque Ramos A; Callhoff J; Albrecht K; Zink A; Hoffmann F
    Z Rheumatol; 2016 Oct; 75(8):819-827. PubMed ID: 27120440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of type 1 and type 2 diabetes before and during the COVID-19 pandemic in Germany: analysis of routine data from 2015 to 2021.
    Reitzle L; Heidemann C; Jacob J; Pawlowska-Phelan D; Ludwig M; Scheidt-Nave C
    J Health Monit; 2023 Nov; 8(Suppl 5):2-25. PubMed ID: 38074488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calculating Ratios Based on Statutory Health Care Data at the District Level - An Empirical Estimation Based on the Microcensus].
    Söhl K; Schulz R; Kuhn J
    Gesundheitswesen; 2017 Jun; 79(6):514-520. PubMed ID: 27171732
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the prevalence of statin use in Germany - findings from national health interview and examination surveys 1997-1999 and 2008-2011].
    Knopf HC; Busch MA; Du Y; Truthmann J; Schienkiewitz A; Scheidt-Nave C
    Z Evid Fortbild Qual Gesundhwes; 2017 May; 122():22-31. PubMed ID: 28511896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.